Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS · Delayed Price · Currency is USD
0.0700
0.00 (0.00%)
Jul 24, 2025, 4:00 PM EDT
Altamira Therapeutics Market Cap
Altamira Therapeutics has a market cap or net worth of $401.23 thousand as of July 24, 2025. Its market cap has decreased by -85.20% in one year.
Market Cap
401.23K
Enterprise Value
-236.34K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
Market Cap Chart
Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 401.23K, a decrease of -99.77%. That is a compound annual growth rate of -42.46%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.66B |
| Veradigm | 781.22M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 568.58M |
| Glass House Brands | 449.22M |
| CytoDyn | 375.37M |
| Northwest Biotherapeutics | 364.65M |